Projets finalisés

2024

  1. Novel comprehensive immunotherapy to specifically target the malignant clone in Sézary syndrome, an ultra-rare cancer of mature T lymphocytes

    JOSÉ RAMÓN REGUEIRO GONZÁLEZ-BARROS